檢索結果 - Haidar Maatouk

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Pharmacokinetics and pharmacodynamics of ponesimod, a selective <scp>S1P<sub>1</sub></scp> receptor modulator, in the first‐in‐human study

    Pharmacokinetics and pharmacodynamics of ponesimod, a selective <scp>S1P<sub>1</sub></scp> receptor modulator, in the first‐in‐human study 由 Patrick Brossard, Hartmut Derendorf, Jian Xu, Haidar Maatouk, Atef Halabi, Jasper Dingemanse

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P<sub>1</sub>receptor modulator: Favorable impact of dose up-titration

    Multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ponesimod, an S1P<sub>1</sub>receptor modulator: Favorable impact of dose up-titration 由 Patrick Brossard, Michael W. Scherz, Atef Halabi, Haidar Maatouk, Andreas Krause, Jasper Dingemanse

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor

    Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor 由 Dagmar Kubitza, Michael Becka, Wolfgang Mueck, Atef Halabi, Haidar Maatouk, Norbert Klause, Volkmar Lufft, Dominic D. Wand, Thomas Philipp, Heike Bruck

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: